Med. praxi. 2018;15(3):167-170 [Prakt. lékáren. 2017; 13(4): 166-168]

Ergotamine-induced coronary artery spasm

Mgr. Andrea Carbolová1, 2, MUDr. Jan Novák2, 3
1 Nemocniční lékárna Fakultní nemocnice u sv. Anny v Brně
2 II. interní klinika Fakultní nemocnice u sv. Anny v Brně
3 Lékařská fakulta Masarykovy univerzity v Brně

For many years, ergotamine has been used for the acute treatment of migraine. In most patients, ergotamine is well tolerated,but also has potential for many side effects. It has been reported, that ergot alkaloids can provoke coronary artery spasm, whichis often associated with ischemic electrocardiography changes and angina pectoris.In the present report, we describe a case involving woman with unclear diagnosed migraine who experienced acute coronarysyndrome most probably because of therapy with ergotamine.To add the knowledge to submitted report, an information about phenomenon of egrotamine overuse headache and aboutcauses of coronary vasospasm are included.

Keywords: ergotamine, migraine, coronary artery spasm

Published: July 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Carbolová A, Novák J. Ergotamine-induced coronary artery spasm. Med. praxi. 2018;15(3):167-170.
Download citation

References

  1. Mastík J. Specifická léčba migrény. Interní medicína pro praxi 2007; 4: 188-191.
  2. Marková J, et al. Nadužívání léků pacienty s chronickou denní bolestí hlavy v České Republice. Česk Slov Neurol N 2011; 74/107(1): 67-71.
  3. Marková J. Bolesti hlavy při nadužívání akutní analgetické medikace. Neurológia pre prax 2012; 13 (1): 15-17.
  4. Headache classification subcomittee of the International Headache Society. The international classification of headache disorders. 3rd edition (beta version). Cephalgia 2013; 33(9): 629-808. Go to original source... Go to PubMed...
  5. Opavský J. Bolesti hlavy vyvolané farmakologicky účinnými látkami nebo jejich vysazením. Klin Farmal Farm 2006; 20: 30-35.
  6. Okutucu S, Karakulak UN, Kabakci G, et al. An unusual cause of chest pain: acute coronary syndrome following administration of ergotamine tartrate. Exp Clin Cardiol 2012; 17(1): 43-44.
  7. Yasue H, Omote S, Takizawa A, et al. Acute myocardial infarction induced by ergotamine tartrate: posible role of coronary arterial spasm. Angiology 1981; 32(6): 414-418. Go to original source... Go to PubMed...
  8. Galer BS, Lipton RB, Solomon S, et al. Myoradial ischemia related to ergot alkaloids. Headache 1991; 31(7): 446-450. Go to original source... Go to PubMed...
  9. Gnecchi-Ruscone T, Lorenzoni R, Anderson D, et al: Effects of ergotamine on myocardial blood flow in migraineurs without evidence of AS coronary artery dinase. Am J cardiol 1998; 81(9): 65-68. Go to original source... Go to PubMed...
  10. Wayne VS. A possible relationship between migraine and coronary artery spasm. Aust N Z J Med 1986; 16(5): 708-710. Go to original source... Go to PubMed...
  11. Hung MJ, Hu P, Hung MY. Coronary artery spasm: Review an update. Int J Med Sci. 2014; 11: 1161-1171. Go to original source... Go to PubMed...
  12. Tfelt-Hansen P, Saxena PR, Dahlof C, et al. Ergotamine in the acute treatment of migraine. A review and European consensus. Brain 2000; 123: 9-18. Go to original source... Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.